Bulk Pharmaceutical API Sources for PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE

Bulk Pharmaceutical API Sources for PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE

Vendor	Vendor Homepage	Vendor Sku	API Url
Starshine Chemical		2023-05-5H02882

Bulk Active Pharmaceutical Ingredient (API) Sources for: PROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE

Last updated: August 1, 2025

---

Introduction

The pharmaceutical industry’s reliance on high-quality Active Pharmaceutical Ingredients (APIs) is foundational to drug efficacy and safety. For medications such as promethazine hydrochloride, phenylephrine hydrochloride with codeine phosphate, sourcing APIs from reliable, compliant suppliers is paramount. This detailed overview examines the global landscape of bulk API sources, emphasizing regulatory compliance, manufacturing quality, and market dynamics pertinent to procurement professionals and pharmaceutical manufacturers.

---

Promethazine Hydrochloride API Sources

Manufacturing markets and supplier landscape

Promethazine hydrochloride, an antihistamine with sedative and antiemetic properties, primarily originates from manufacturers situated in India, China, and Eastern Europe. India stands out as a dominant supplier, driven by its extensive generic API manufacturing sector aligned with Good Manufacturing Practices (GMP) and competitive pricing.

Key suppliers and their capabilities

• Divi’s Laboratories (India): A global leader in API manufacturing, Divi’s offers promethazine hydrochloride produced under GMP conditions, with proven regulatory track records, including approvals from the US FDA and EMA. Their facilities operate under ISO 9001 standards, ensuring batch-to-batch consistency.

• Granules India (India): Known for cost-effective APIs, Granules India has a robust API portfolio with products complying with international pharmaceutical standards. Their promethazine hydrochloride API is marketed globally and adheres to pharmacopoeial specifications.

• Sino Pharmaceutical (China): Offers APIs that conform to pharmacopoeial standards, with certifications acceptable in global markets. They emphasize quality control and supply chain stability.

Regulatory considerations

API suppliers must demonstrate compliance with GMP, ISO certifications, and ensure regulatory dossiers are in place. For global market access, suppliers with prior audits, such as by the US FDA or EMA, are preferred. Transparency regarding manufacturing processes and quality control is critical.

---

Phenylephrine Hydrochloride with Codeine Phosphate API Sources

Market Overview

The combination of phenylephrine hydrochloride with codeine phosphate is widely used for treating cough and cold symptoms. Sourcing APIs for this combination involves sourcing individual APIs from different manufacturers, often combining them during formulation. The complexity increases with regulations surrounding codeine, classified as a controlled substance.

Phenylephrine Hydrochloride

• Leading suppliers: India and China dominate phenylephrine API production owing to their extensive chemical synthesis capabilities.

• Notable manufacturers:

  • SudaPharm (India): Provides phenylephrine hydrochloride with GMP compliance, ISO certification, and extensive regulatory approvals.

  • Shandong Xinhua Pharmaceutical (China): Supplies phenylephrine API conforming to pharmacopoeial standards, with consistent quality records.

Codeine Phosphate

• Regulatory restrictions: As a controlled substance (Schedule II or III depending on jurisdiction), sourcing codeine APIs entails rigorous legal compliance, licensing, and documentation.

• Major producers:

  • Indo German Drugs, Ltd. (India): Offers pharmaceutical-grade pseudophases of codeine phosphate, compliant with regulatory standards.

  • Mada Pharmaceuticals (India): Offers controlled substance APIs with requisite licenses and security measures.

Combination manufacturing considerations

Manufacturers sourcing phenylephrine and codeine APIs must navigate complex legal frameworks, including import/export controls, record-keeping, and security standards. Suppliers with established compliance and legal clearance are preferred.

---

Global API Sourcing Strategies

Diversification and risk mitigation

Reliance on single-source suppliers exposes companies to supply disruptions and quality risks. A diversified supplier base spanning multiple regions—India, China, Eastern Europe—enhances supply chain resilience.

Regulatory diligence

Due diligence on supplier GMP compliance, audit history, and regulatory certifications ensures API quality. Engaging with suppliers holding prior FDA, EMA, or local regulatory approvals reduces compliance risks.

Cost and lead time considerations

While India and China offer cost advantages, political, logistical, and regulatory factors influence supplier choice. Leading manufacturers with established export channels tend to offer reliable delivery timelines.

---

Current Market Trends and Challenges

• Supply Chain Disruptions: COVID-19 underscored vulnerabilities in global API supply chains, prompting manufacturers to evaluate stock levels and diversify suppliers.

• Regulatory Stringency: Increasing scrutiny on APIs, especially for controlled substances like codeine, mandates comprehensive documentation and compliance audits.

• Quality Expectations: Growing demand for high-purity, well-characterized APIs drives suppliers to invest in advanced manufacturing and quality assurance systems.

• Environmental and Ethical Standards: Sustainability practices, ingredient traceability, and adherence to environmental regulations influence supplier selection.

---

Conclusion

Sourcing bulk APIs for promethazine hydrochloride and phenylephrine hydrochloride with codeine phosphate requires a strategic approach emphasizing compliance, quality, reliability, and regulatory navigation. India remains a primary hub, with China providing cost-effective options, both supported by increasing regulatory oversight. Engaging with reputable manufacturers affiliated with stringent quality standards is integral to ensuring consistent API supply, regulatory approval, and patient safety.

---

Key Takeaways

• Indian manufacturers like Divi’s Laboratories and Granules India are leading suppliers for promethazine hydrochloride and phenylephrine APIs, respectively, with established regulatory compliance.

• API sourcing for controlled substance components like codeine phosphate demands rigorous legal and security compliance, necessitating partnerships with licensed, reputable suppliers.

• Diversification across geographic regions minimizes supply risks; however, suppliers’ regulatory track records and GMP compliance are critical decision factors.

• Market dynamics are influenced by regulatory tightening and supply chain vulnerabilities, prompting proactive sourcing strategies.

• Partnering with suppliers demonstrating transparency, regulatory adherence, and environmental responsibility ensures supply chain integrity and product quality.

---

FAQs

1. What are the primary regions supplying promethazine hydrochloride API globally?
   India leads as the primary supplier, followed by China and Eastern European countries, owing to their extensive chemical manufacturing infrastructure.

2. How do I verify the regulatory compliance of API suppliers?
   Review certifications such as GMP, ISO, and inspection reports from agencies like the US FDA, EMA, or local authorities. Engage in supplier audits and request detailed documentation.

3. What should be considered when sourcing APIs containing controlled substances like codeine?
   Legal licensing, security protocols, import/export permissions, and adherence to local and international drug control regulations are essential considerations.

4. Are there quality differences between API sources from different regions?
   High-quality APIs are available worldwide; however, adherence to GMP standards, transparency in manufacturing processes, and regulatory approval history are indicators of quality regardless of origin.

5. How can supply chain risks be mitigated when sourcing APIs?
   Diversify suppliers across regions, maintain safety stock, conduct periodic audits, and develop contingency plans for potential disruptions to ensure uninterrupted supply.

---

References

1. U.S. Food & Drug Administration (FDA). GMP Compliance Data.
2. European Medicines Agency (EMA). API Manufacturers Directory.
3. Global Suppliers Database. Pharmaceutical API Market Reports.
4. Indian Pharmaceutical Alliance. API Industry Insights.
5. Chinese Pharmacopoeia. API Standards.